Cattle provide collagen at Collatech Pharm:
This article was originally published in Clinica
Israeli development-stage company Collatech Pharm has developed a collagen from the hide of cattle for use in a range of wound care procedures. The company says the collagen base is non-immunogenic, non-toxic and can be blended with other substances to promote healing. It can be used in sponge form for haemostasis during surgery or in reconstructive surgery where the dissolving time of the collagen can be set.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.